Barcelona 2015 Programme Registration Glaucoma Day 2015 Exhibition Virtual Exhibition Satellite Meetings Hotel Booking Star Alliance
ISTANBUL escrs









Take a look inside the London 2014 Congress

video-icon

Then register to join us
in Barcelona!





Meibography patterns with Keratograph 5M

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Session Details

Session Title: Presented Poster Session: Dry Eye and Inflammation

Session Date/Time: Monday 07/09/2015 | 15:00-16:30

Paper Time: 15:00

Venue: Poster Village: Pod 3

First Author: : L.Modamio-Gardeta SPAIN

Co Author(s): :    L. Martin-Perez   M. Matilla-Rodero   J. Fernandez-Garcia   N. Kim   S. De Manuel-Triantafilo   A. Arias-Puente

Abstract Details

Purpose:

To describe different morphological patterns of the palpebral glands using a novel non-contact meibography system.

Setting:

A sample of 30 patient was studied at the ophthalmology department of Hospital Universitario Fundación Alcorcón of Madrid.

Methods:

The upper and lower eyelids glands were observed after eversion using the Oculus Keratograph 5M, a non-contact meibography system based in placido discs with an infrared illumination system. The glandular tissue loss and destructuration was scored in grades from 0 to 3 depending on the size of the affected area (0= no loss or destructuration of meibomian glands; 1= area loss less than 1/3 of the glandular area 2=area loss between 1/3 and 2/3; 3= area loss more than 2/3). Different cases are presented to illustrate the morphological characteristics of glandular tissue most commonly encountered in clinical practice.

Results:

In all cases, the obtained images allowed to classify the morphology and loss of the glandular tissue in one of the established patterns.

Conclusions:

This non-contact infrared meibography digital system provides images of the meibomian glands in a quick and non-invasive way. The obtained meibographies can allow to correlate the findings in the glandular morphology with clinical symptoms and other parameters of the ocular surface.

Financial Disclosure:

NONE

Back to previous